首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-human CD127 (IL-7Rα) A
产品名称:
PerCP/Cyanine5.5 anti-human CD127 (IL-7Rα) A
产品类别:
抗体
产品编号:
351321
产品应用:
351321
[价格]
规格 价格 库存
25tests ¥ 188 1

产品详情

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cynomolgus, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Recombinant human CD127
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Additional reported (for the relevant formats) application: proteogenomics1.

Additional Product Notes
View more applications data for this product in our Scientific Poster Library.

BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  2. Palamides P, et al. 2016. Dis Model Mech. 9: 985 - 997. PubMed
  3. Ramien C, et al. 2020. Cell Reports. 29(4):810-815. PubMed
  4. Roukens AHE, et al. 2022. Nat Immunol. 23:23. PubMed
  5. Pan YG, et al. 2021. Immunity. 54(6):1245-1256.e5. PubMed
  6. Wu J, et al. 2021. Front Immunol. 12:601611. PubMed
  7. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  8. Goodwin M, et al. 2020. Sci Adv. 6:eaaz0571. PubMed
  9. Chen Y, et al. 2021. Transl Lung Cancer Res. 10:2193. PubMed
  10. Fujigaki J, et al. 2015. PLoS One. 10: 0132521. PubMed
  11. Shen C, et al. 2021. Front Immunol. 12:680055. PubMed
  12. Van Zeebroeck L, et al. 2021. Front Immunol. 12:655122. PubMed
  13. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  14. Santoni de Sio FR, et al. 2018. J Allergy Clin Immunol. 142:1909. PubMed
  15. Hui Z, et al. 2022. Cell Death Dis. 13:607. PubMed
RRID
AB_10900253 (BioLegend Cat. No. 351321) AB_10897104 (BioLegend Cat. No. 351322)

Antigen Details

Structure
Type I transmembrane glycoprotein, associates with CD132, 60-90 kD
Distribution

Immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, bone marrow stromal cells

Function
T cell and immature B cell proliferation and development
Ligand/Receptor
IL-7
Cell Type
B cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References

1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125.
2. He YW and Malek TR. 1998. Crit. Rev. Immunol. 18:503.
3. Huster KM, et al. 2004. P. Natl. Acad. Sci. USA 101:5610.
4. Pillai M, et al. 2004. Leukemia Lymphoma 45:2403.
5. Morrissey PJ, et al. 1989. J. Exp. Med. 169:707.
6. Liu W, et al. 2006. J. Exp. Med. 203:1701.

Gene ID
3575 View all products for this Gene ID
UniProt
View information about CD127 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线